Parametric Portfolio Associates’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
$7.27M Sell
224,892
-7,806
-3% -$252K ﹤0.01% 1589
2021
Q4
$6.79M Buy
232,698
+59,141
+34% +$1.72M ﹤0.01% 1655
2021
Q3
$4.63M Buy
173,557
+24,873
+17% +$663K ﹤0.01% 1881
2021
Q2
$4.58M Sell
148,684
-8,908
-6% -$274K ﹤0.01% 1899
2021
Q1
$4.13M Sell
157,592
-15,644
-9% -$410K ﹤0.01% 2308
2020
Q4
$4.36M Buy
173,236
+23,648
+16% +$595K ﹤0.01% 2158
2020
Q3
$3.12M Buy
149,588
+7,401
+5% +$154K ﹤0.01% 2220
2020
Q2
$3.38M Buy
142,187
+56,118
+65% +$1.33M ﹤0.01% 2149
2020
Q1
$1.55M Sell
86,069
-29,223
-25% -$526K ﹤0.01% 2540
2019
Q4
$2.74M Sell
115,292
-40,480
-26% -$960K ﹤0.01% 2482
2019
Q3
$4.28M Sell
155,772
-5,012
-3% -$138K ﹤0.01% 2126
2019
Q2
$5.32M Sell
160,784
-45,937
-22% -$1.52M ﹤0.01% 1968
2019
Q1
$7.24M Sell
206,721
-71,896
-26% -$2.52M 0.01% 1675
2018
Q4
$9.26M Sell
278,617
-60,426
-18% -$2.01M 0.01% 1388
2018
Q3
$17.1M Sell
339,043
-60,691
-15% -$3.06M 0.01% 1008
2018
Q2
$23.9M Buy
399,734
+19,903
+5% +$1.19M 0.02% 733
2018
Q1
$17.4M Buy
379,831
+71,442
+23% +$3.27M 0.02% 914
2017
Q4
$12.3M Sell
308,389
-27,458
-8% -$1.09M 0.01% 1164
2017
Q3
$13.4M Buy
335,847
+28,716
+9% +$1.15M 0.01% 1006
2017
Q2
$13.2M Buy
307,131
+28,446
+10% +$1.23M 0.02% 970
2017
Q1
$8.72M Buy
278,685
+26,417
+10% +$827K 0.01% 1258
2016
Q4
$6.37M Buy
252,268
+32,626
+15% +$824K 0.01% 1453
2016
Q3
$5.43M Sell
219,642
-1,854
-0.8% -$45.9K 0.01% 1492
2016
Q2
$4.51M Buy
221,496
+28,875
+15% +$588K 0.01% 1626
2016
Q1
$2.94M Buy
192,621
+154,929
+411% +$2.36M ﹤0.01% 2073
2015
Q4
$507K Buy
37,692
+226
+0.6% +$3.04K ﹤0.01% 3235
2015
Q3
$526K Buy
37,466
+10,864
+41% +$153K ﹤0.01% 2694
2015
Q2
$452K Buy
+26,602
New +$452K ﹤0.01% 3345